Home › Stargardt Disease › Massachusetts › Boston
Stargardt Disease clinical trials in Boston, MA
4 studies for Stargardt Disease are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
RecruitingObservational study
- Massachusetts Eye and Ear, Boston
- Boston Children's Hospital, Boston
Study of ALK-001 on the Progression of Stargardt Disease
RecruitingPhase 3
- Tufts Medical Center - New England Eye Center, Boston
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
RecruitingObservational study
- Massachusetts Eye and Ear Infirmary, Boston
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
RecruitingPhase 1/2
- Massachusetts Eye and Ear Infirmary, Boston
Stargardt Disease trials in other cities
- Dallas, TX8 studies
- Phoenix, AZ4 studies
- Houston, TX3 studies
- Pittsburgh, PA3 studies
- Portland, OR3 studies
- Ann Arbor, MI3 studies
- Gainesville, FL3 studies
- Miami, FL3 studies
- Aurora, CO3 studies
- Cincinnati, OH3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.